DiscoverSounds of ScienceOff-Target, On-Point: How Retrogenix® Reduces Risk and Animal Use
Off-Target, On-Point: How Retrogenix® Reduces Risk and Animal Use

Off-Target, On-Point: How Retrogenix® Reduces Risk and Animal Use

Update: 2025-09-02
Share

Description

In this episode of Sounds of Science, learn how the Retrogenix® platform is reshaping drug development by identifying off-target risks earlier, reducing animal use, and gaining traction with regulators—now as part of the FDA’s ISTAND pilot program. Guests Nick Brown and Mark Aspinall-O’Dea from Charles River Discovery Services share real-world insights on their role in advancing NAMs and supporting safer, faster therapeutic development.

Show Notes 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Off-Target, On-Point: How Retrogenix® Reduces Risk and Animal Use

Off-Target, On-Point: How Retrogenix® Reduces Risk and Animal Use

Charles River